| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.2 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.22 | 0.2 |